EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating the Dose-Dependent Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Preclinical Model of Interstitial Lung Disease

Takuya Kotani, Takashi Saito iD, Ryota Masutani, Satsuki Uemura, Shogo Matsuda, Takayasu Suzuka, Masaki Ikemoto, Tohru Takeuchi iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262010016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Takuya Kotani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine (IV), Division of Rheumatology, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Osaka, Japan. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation, Umbilical Cord, Lung Diseases, Interstitial. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interstitial lung disease associated with connective tissue disease (CTD-ILD) is a severe condition characterized by inflammation and progressive lung fibrosis, with limited treatment options. Previous studies have demonstrated the anti-inflammatory and antifibrotic properties of human umbilical cord-derived mesenchymal stem cells (huMSCs), suggesting their potential as novel therapeutic agents. Therefore, we investigated the dose-dependent therapeutic effects of huMSCs on CTD-ILD. A bleomycin-induced mouse model of interstitial lung disease, in which female C57BL/6J mice developed diffuse pulmonary lesions following continuous subcutaneous infusion of bleomycin, was used. Mice subsequently received intravenous huMSCs at doses of 1.0 × 103, 1.0 × 104, or 1.0 × 105 cells. The medium dose (1.0 × 104 cells) showed the most pronounced effects on pulmonary fibrosis and collagen deposition, while significantly suppressing pro-inflammatory cytokines, including interleukin-1β and interleukin-6; however, this effect was not consistent across all measured outcomes. The treatment also enhanced beneficial matrix remodeling by downregulating TIMP-1 and upregulating MMP-9 expression. Furthermore, huMSC administration modulated macrophage polarization and inhibited the pro-inflammatory M1 phenotype. These findings highlight the therapeutic potential of huMSCs for CTD-ILD and underscore the importance of dose optimization to balance efficacy and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsMesenchymal Stem Cell TransplantationUmbilical CordLung Diseases, InterstitialAnimalsHumansMiceFemaleDisease Models, AnimalMice, Inbred C57BLBleomycinMatrix Metalloproteinase 9Pulmonary FibrosisCytokinesMacrophagesTissue Inhibitor of Metalloproteinase-1

Stichwörter der Autor:innen

MMP-9TIMP-1connective tissue diseasehuman umbilical cord-derived mesenchymal stem cellinterstitial lung disease

Substanzen

BleomycinMatrix Metalloproteinase 9CytokinesTissue Inhibitor of Metalloproteinase-1

Autor:innen und Institutionen

  • Department of Internal Medicine (IV), Division of Rheumatology, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Osaka, Japan.
  • Department of Legal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Osaka, Japan.
  • Laboratory of Microbial Informatics, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki 567-0085, Osaka, Japan.
  • Division of Central Laboratory, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Osaka, Japan.
  • School of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Osaka, Japan.

ORCID-Profile: Takashi Saito, Tohru Takeuchi

Förderung

  • JSPS KAKENHI

Zitieren

APA

Kotani, T., Saito, T., Masutani, R., Uemura, S., Matsuda, S., Suzuka, T., Ikemoto, M., & Takeuchi, T. (2025). Evaluating the Dose-Dependent Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Preclinical Model of Interstitial Lung Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010016

Vancouver

Kotani T, Saito T, Masutani R, Uemura S, Matsuda S, Suzuka T, et al. Evaluating the Dose-Dependent Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Preclinical Model of Interstitial Lung Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010016

BibTeX
@article{Kotani2025,
  author = {Kotani, Takuya and Saito, Takashi and Masutani, Ryota and Uemura, Satsuki and Matsuda, Shogo and Suzuka, Takayasu and Ikemoto, Masaki and Takeuchi, Tohru},
  title = {Evaluating the Dose-Dependent Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Preclinical Model of Interstitial Lung Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262010016}
}
Kostenlos starten →